Insider Trading November 19, 2026 01:00 AM

Peoples Bancorp Director Adds 200 Shares in Open-Market Purchase

Dr. Billy L. Price Jr. acquires $8,284 in common stock at $41.42 per share, lifting his direct stake to 15,643.89 shares.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
PEBK

Dr. Billy L. Price Jr., a director at Peoples Bancorp of North Carolina Inc. (NASDAQ:PEBK), purchased 200 shares of the company's common stock on November 18, 2026, at $41.42 per share, for a total of $8,284. The transaction increases his direct holdings to 15,643.89 shares. The purchase comes as PEBK trades at a price-to-earnings ratio of 10.37 and has returned 44% over the past year. An analysis cited in the original report suggests the stock appears overvalued relative to its Fair Value. The company maintains a 2% dividend yield and has paid dividends for 42 consecutive years. The article also notes that five additional exclusive tips are available for PEBK investors.

Peoples Bancorp Director Adds 200 Shares in Open-Market Purchase
PEBK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Dr. Billy L. Price Jr., a director at Peoples Bancorp of North Carolina (PEBK), bought 200 shares at $41.42 per share on November 18, 2026, for a total of $8,284, raising his direct holdings to 15,643.89 shares.
  • The purchase comes as PEBK trades at a P/E ratio of 10.37 and has returned 44% over the past year, while an analysis cited in the report suggests the stock appears overvalued relative to its Fair Value.
  • Peoples Bancorp maintains a 2% dividend yield and has paid dividends for 42 consecutive years, a record that may be relevant to income-focused investors in the banking sector.

Dr. Billy L. Price Jr., a member of the board of directors at Peoples Bancorp of North Carolina Inc. (NASDAQ:PEBK), has added to his position in the company's common stock, according to a recent disclosure. The director acquired 200 shares on November 18, 2026, at a price of $41.42 per share, for a total transaction value of $8,284.

Following the purchase, Dr. Price directly holds 15,643.89 shares of Peoples Bancorp of North Carolina Inc., the filing shows. The open-market buy represents a modest increase in his direct ownership stake.

The insider transaction arrives at a moment when PEBK is changing hands at a price-to-earnings ratio of 10.37. Over the trailing twelve months, the stock has delivered a return of 44%. Despite that performance, an analysis referenced in the original report indicates that the shares currently appear overvalued relative to their Fair Value.

Peoples Bancorp of North Carolina also maintains a dividend yield of 2% and has demonstrated consistency in returning capital to shareholders, with 42 consecutive years of dividend payments. The report notes that five additional exclusive tips are available for investors seeking deeper insights into PEBK.

The disclosed purchase reflects a director's decision to acquire shares in the open market. It does not, by itself, indicate a change in the company's fundamental outlook or performance. Investors often monitor insider buying and selling for signals about how executives and directors view the value of their company's stock, though such transactions can be motivated by a variety of personal financial considerations.

The article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risks

  • The article notes that PEBK appears overvalued relative to its Fair Value based on the cited analysis, which could imply valuation risk for the stock and potentially affect sentiment toward small-cap bank shares.
  • Insider buying activity may not reliably predict future performance, and the report does not provide context on the director's motivation, leaving room for uncertainty about the signal's significance for the banking sector.

More from Insider Trading

VSE Corp CEO John Cuomo Offloads $338,964 in Stock Under Pre-Arranged Plan Nov 19, 2026 Morningstar's Mansueto Offloads $1.8 Million in Shares Near 52-Week High Nov 19, 2026 Motorsport Games CFO Peter Hansen-Chambers Discloses $9,793 Share Purchase Nov 19, 2026 Atara Bio CEO Offloads $39,368 in Shares to Cover Tax Bill Nov 19, 2026 CorMedix Director Myron Kaplan Discloses $122,000 Open-Market Share Purchase Nov 19, 2026